drugset / Trial / NCT03339921

Botulinum for Chronic Exertional Compartment Syndrome

NCT03339921

Phase 2/3 Terminated 3 enrolled 375th Medical Group, Scott Air Force Base
Non-randomizedParallel-groupOpen-labelTreatment

Summary

We will investigate the feasibility of a simple outpatient one time injection regimen for the treatment of Chronic Exertional Compartment Syndrome (CECS). We think botulinum toxin injections will be a potentially cost-effective, low-risk alternative to surgery in reducing pain and returning patients to full activity.

Timeline

Start
2018-12-07
Primary completion
2020-05-01
Completion
2020-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin Protein / enzyme biologic Other

Indications